about
Vitamin B for treating diabetic peripheral neuropathyNatural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a TargetDiabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalitiesBrain changes in diabetes mellitus patients with gastrointestinal symptomsThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingTargeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathyMethylglyoxal evokes pain by stimulating TRPA1The Effect of Noscapine on Oxygen-Glucose Deprivation on Primary Murine Cortical Neurons in High Glucose ConditionEfficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-AnalysisVascular-dependent effects of elevated glucose on postganglionic sympathetic neurons.An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Is Diabetic Nerve Pain Caused by Dysregulated Ion Channels in Sensory Neurons?Painful Diabetic Neuropathy: Prevention or Suppression?Is fenofibrate a reasonable treatment for diabetic microvascular disease?Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channelsCaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling.Automated sample preparation in a microfluidic culture device for cellular metabolomicsThe management of diabetic neuropathy in CKD.Literature-based discovery of diabetes- and ROS-related targets.Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.Diabetic neuropathy part 1: overview and symmetric phenotypesp38 mediates mechanical allodynia in a mouse model of type 2 diabetes.The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients.Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.Mechanisms of disease: the oxidative stress theory of diabetic neuropathyHyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.Autonomic test by EZSCAN in the screening for prediabetes and diabetesGinsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.Effect of serum containing Jinmaitong Capsule on rats' Schwann cell apoptosis induced by high glucose concentration.Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodentsDiabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.Hyperinsulinemia induces insulin resistance in dorsal root ganglion neuronsCombined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: a systematic review and a meta-analysis of Chinese studiesThe identification of gene expression profiles associated with progression of human diabetic neuropathy
P2860
Q26471719-F5D124D4-36B4-4565-B3FB-71875D6E451FQ26741391-783FDEE1-C349-4BAA-BE04-65FDF9557109Q26748554-577A086C-1187-45B5-B5AE-156B754EF556Q26769999-F56D6F00-DDAB-4BDF-AFDA-606E717D8F77Q28248377-986FDF08-867D-4A0C-81E0-BC987ED3B9A9Q28306961-7AE32D30-B692-4C10-B3D4-8BCA266AA9B6Q28534579-30E073A0-63FF-43DE-B894-6CD8C051AFEBQ28830706-4C93E052-0BDC-4A0E-8089-644B0F7580AAQ28972373-B777AE71-73A7-48B6-9A39-E0A97256832FQ29347086-71E66177-F52F-437D-8DB0-6494803ACF78Q30236003-6D0EA26B-E5CF-4EB4-85AC-B94CB2887D4AQ30278025-9CD59FF4-A354-4DA3-B5C9-4C71434EAF1BQ30352607-7C03461F-8FA4-45F5-9841-B1FB55A79D2EQ30372692-3C9582BF-21C9-45E0-B83C-64911121C5DEQ30409746-55218DD4-A196-4140-8BC9-8085CF1A260BQ30413912-C2E72F31-A073-4DF6-9A48-51A2336FB659Q30424352-B9A1B4E2-2A55-4B6E-8B57-8FC15B49E56BQ30456403-4C735036-8929-4B0B-84B3-AC58AF938425Q30770430-06930049-5A6C-47A3-AB83-87597190342CQ33554396-CED7EC49-BB9B-4475-9385-CE89A4948C27Q33729719-02CDE0D2-0AF8-45B4-B15F-0674EE02B80EQ33862382-83B1C462-D65A-4CBB-9E5F-1BC75017E478Q33878023-3810F2F4-2378-4390-875B-8FB9BB685F63Q33895067-2108A448-EB19-4883-9023-522717243AEAQ33904484-72869839-2A1B-4EF2-974B-F311EF37B96CQ34115301-5EA16284-9786-4ABC-9ABD-799B741F1CF2Q34135732-D88A6D72-4B8E-4226-AA4C-3A8FD0FDC781Q34553052-96F9A20F-7A9F-429E-A429-D6836BFEAD5FQ34562861-B252CD7F-595C-49E1-ACC6-5C889DCE4F2FQ34592852-ACF8803A-2979-478D-9E6D-7C47B9757141Q34720246-73F0D3DF-8C45-4227-A40C-0A2847ADAB33Q34789025-31C335AC-8437-427B-8A5F-03CDC61C9C9AQ34805939-A2A042EF-8990-4942-A527-781BCC4A97B8Q35063229-2F88DE41-409F-43CF-BF7A-B20BA5C7BF98Q35141164-F081415E-7586-4E80-8197-89DC9AA0F40CQ35179226-6B99C565-0D09-40F5-ABA5-AEC32A8E6961Q35189552-6DD47FE7-C253-449C-AF9B-4369EC0CA820Q35223053-7360730A-C72B-4A80-929F-1BA6144EE605Q35249711-A2393416-7826-44D7-8B09-72D6AEE00221Q35540055-E9CC904A-8296-468A-920C-8C1AD0CA35A3
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Diabetic neuropathy: mechanisms to management
@ast
Diabetic neuropathy: mechanisms to management
@en
Diabetic neuropathy: mechanisms to management.
@nl
type
label
Diabetic neuropathy: mechanisms to management
@ast
Diabetic neuropathy: mechanisms to management
@en
Diabetic neuropathy: mechanisms to management.
@nl
prefLabel
Diabetic neuropathy: mechanisms to management
@ast
Diabetic neuropathy: mechanisms to management
@en
Diabetic neuropathy: mechanisms to management.
@nl
P2093
P2860
P1476
Diabetic neuropathy: mechanisms to management
@en
P2093
Andrea M Vincent
Hsinlin T Cheng
James L Edwards
P2860
P356
10.1016/J.PHARMTHERA.2008.05.005
P577
2008-06-13T00:00:00Z